Publication
Title
Image-guided conformation arc therapy for prostate cancer: Early side effects
Author
Abstract
Purpose: To evaluate early side effects in prostate cancer patients treated with image-guided conformation arc therapy (IGCAT) using a minimultileaf collimator and daily X-ray-assisted patient positioning. Methods and Materials: Between May 2000 and November 2004, 238 cT1-T3N0M0 tumors were treated with doses of 70 or 78 Gy. Seventy patients also received neoadjuvant or concurrent hormonal treatment. Median follow-up is 18 months (range, 4-55 months). The Radiation Therapy Oncology Group and the European Organization for Research and Treatment of Cancer toxicity scoring system was used to evaluate early side effects. Results: Grade 1, 2, and > 2 acute side effects occurred in 19, 6, and 0% (gastrointestinal) and 37, 16, and 0% (genitourinary) of the patients. No relation between radiation dose and early side effects was observed. Conclusion: Patients treated with image-guided conformation arc therapy experience a low rate of Grade 2 (i.e., requiring medication) early side effects. The definitive evaluation of late side effects and biochemical control requires further follow-up. (c) 2006 Elsevier Inc.
Language
English
Source (journal)
International journal of radiation oncology, biology, physics. - Bedford
Publication
Bedford : 2006
ISSN
0360-3016
DOI
10.1016/J.IJROBP.2006.05.077
Volume/pages
66 :4s:[S] (2006) , p. S141-S144
ISI
000241738400024
Full text (Publisher's DOI)
UAntwerpen
Publication type
Subject
External links
Web of Science
Record
Identifier
Creation 04.12.2019
Last edited 20.08.2024
To cite this reference